Observatory · observe first
Follow the allocation change
Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.
Historical time machine
Historical observation
20182026
1 · Sector
Weight and 12M allocation change
2 · Industry
Inside Health Care
Biotechnology2.84%-0.58 ppPharmaceuticals6.10%+0.56 ppHealth Care Equipment3.33%+0.45 ppHealth Care Services1.01%+0.35 ppLife Sciences Tools & Services1.82%+0.32 ppManaged Health Care2.16%+0.22 ppHealth Care Distributors0.39%-0.10 ppHealth Care Facilities0.28%+0.07 ppHealth Care Supplies0.14%-0.00 ppHealth Care Technology0.00%+0.00 pp
3 · Sub-industry
Inside Biotechnology
Biotechnology · weight
2.84%
Industry change · 12M
-0.58 pp
Biotechnology · contribution
-0.582 pp
Company participation
100%
of industry constituents above their 6M weight average
4 · Companies driving this sub-industry
Feb 2019 · sorted by absolute contribution to 12-month change
| Company | Country | Market cap | Universe weight | 3M contribution | 12M contribution | 12M price return | Above 6M weight average |
|---|---|---|---|---|---|---|---|
| AbbVie → ABBV | United States | $116.9bn | 0.678% | +0.206 pp | -0.425 pp | -28.6% | Yes |
| Gilead Sciences → GILD | United States | $82.9bn | 0.481% | +0.172 pp | -0.137 pp | -14.8% | Yes |
| Amgen → AMGN | United States | $118.3bn | 0.686% | +0.245 pp | -0.108 pp | +6.5% | Yes |
| Regeneron Pharmaceuticals → REGN | United States | $40.5bn | 0.235% | +0.120 pp | +0.054 pp | +34.4% | Yes |
| Vertex Pharmaceuticals → VRTX | United States | $48.3bn | 0.280% | +0.126 pp | +0.027 pp | +13.7% | Yes |
| Biogen → BIIB | United States | $64.5bn | 0.374% | +0.151 pp | +0.008 pp | +13.5% | Yes |
| Incyte → INCY | United States | $18.5bn | 0.107% | +0.062 pp | -0.001 pp | +1.3% | Yes |
Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.